Xylem (NYSE:XYL) Given New $145.00 Price Target at Royal Bank of Canada

Xylem (NYSE:XYLFree Report) had its target price increased by Royal Bank of Canada from $140.00 to $145.00 in a report issued on Wednesday, Benzinga reports. The firm currently has an outperform rating on the industrial products company’s stock.

A number of other brokerages have also recently weighed in on XYL. Oppenheimer upgraded shares of Xylem from a market perform rating to an outperform rating and set a $118.00 price target for the company in a research note on Thursday, October 19th. Citigroup upped their price objective on shares of Xylem from $104.00 to $109.00 and gave the stock a neutral rating in a research report on Monday, December 11th. Raymond James upgraded shares of Xylem from an underperform rating to a market perform rating in a research report on Thursday, January 4th. Wolfe Research initiated coverage on shares of Xylem in a research report on Wednesday, December 13th. They set an outperform rating and a $127.00 price objective for the company. Finally, Stifel Nicolaus upped their price objective on shares of Xylem from $133.00 to $136.00 and gave the stock a buy rating in a research report on Tuesday, December 19th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Xylem presently has a consensus rating of Moderate Buy and an average target price of $125.40.

Check Out Our Latest Analysis on XYL

Xylem Stock Up 3.2 %

Shares of NYSE:XYL opened at $123.35 on Wednesday. The stock has a market cap of $29.74 billion, a P/E ratio of 45.35, a P/E/G ratio of 2.14 and a beta of 1.09. The firm has a fifty day moving average price of $111.72 and a 200 day moving average price of $102.92. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.21. Xylem has a 1-year low of $87.59 and a 1-year high of $124.56.

Xylem (NYSE:XYLGet Free Report) last issued its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.03. The firm had revenue of $2.12 billion during the quarter, compared to analysts’ expectations of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. Xylem’s quarterly revenue was up 40.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.92 EPS. Sell-side analysts predict that Xylem will post 4.06 EPS for the current year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date is Tuesday, February 20th. This is an increase from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio (DPR) is currently 48.53%.

Insider Activity

In other news, CEO Patrick Decker sold 99,648 shares of the stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $100.84, for a total value of $10,048,504.32. Following the completion of the transaction, the chief executive officer now owns 287,564 shares in the company, valued at approximately $28,997,953.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Victoria D. Harker sold 2,000 shares of the stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $106.50, for a total value of $213,000.00. Following the sale, the director now directly owns 20,679 shares of the company’s stock, valued at approximately $2,202,313.50. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Patrick Decker sold 99,648 shares of the stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $100.84, for a total transaction of $10,048,504.32. Following the completion of the sale, the chief executive officer now directly owns 287,564 shares in the company, valued at $28,997,953.76. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Institutional Trading of Xylem

A number of large investors have recently made changes to their positions in the stock. Financial Gravity Asset Management Inc. purchased a new position in shares of Xylem during the 2nd quarter worth $63,000. Bruce G. Allen Investments LLC acquired a new position in Xylem in the fourth quarter valued at $27,000. Your Advocates Ltd. LLP purchased a new position in Xylem during the second quarter worth about $34,000. Massmutual Trust Co. FSB ADV boosted its stake in Xylem by 49.3% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 318 shares of the industrial products company’s stock worth $36,000 after buying an additional 105 shares during the last quarter. Finally, Coppell Advisory Solutions LLC acquired a new stake in Xylem in the 2nd quarter worth about $45,000. Institutional investors and hedge funds own 84.53% of the company’s stock.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

See Also

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.